AlphAIAlphAI — Financial news for AI agents
rttnews.comOCT 283 min read$BLCO

Bausch + Lomb Swings To Profit In Q3, Lifts FY26 Guidance; Pre-market Shares Up

Bausch + Lomb (BLCO) reported a Q3 2026 profit of $32M ($0.09/Share) vs. a loss last year, with revenue up 7% to $1.38B. Guidance raised: FY26 revenue now $5.45B-$5.55B, adjusted EBITDA $1.09B-$1.14B. Pre-market shares up 2.1%.

Original reporting
rttnews.com
Published Oct 28, 2026, 12:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 12:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Bausch + Lomb Swings To Profit In Q3, Lifts FY26 Guidance; Pre-market Shares Up — source image
Source · rttnews.com
Decision brief

The 30-second read

$BLCOBullishMed
01

Why it matters

The key market catalyst is the combination of a Q3 profit swing and raised FY26 revenue and adjusted EBITDA guidance ranges, which can change FY26 earnings power expectations.

02

Market read

This is a direct earnings-and-guidance update with specific FY26 ranges, making it actionable for near-term positioning and expectation-setting.

03

What to watch

Traders may discount the adjusted EBITDA metric if it excludes items investors view as recurring, and will watch whether segment growth (Vision Care, Surgical, Pharmaceuticals) is sustainable into FY26.

Relevance 9/10Novelty 8/10Timing: pre-market today

Background

Bausch + Lomb is a global eye-care company reporting quarterly results by Vision Care, Surgical, and Pharmaceuticals segments.

Company-level read

Ticker impact

$BLCOBullishHigh confidence
Context

Bausch + Lomb reported Q3 fiscal 2026 return to profit and raised FY26 revenue and adjusted EBITDA guidance in pre-market trading.

Expected impact

Likely upward pressure as the market reprices FY26 revenue and adjusted EBITDA expectations after the guidance raise.

Evidence & confidence

The article discloses a profit swing (net income vs prior-year loss) plus higher full-year revenue and adjusted EBITDA ranges, which are direct valuation drivers.

Market effects

Sector

Positive read-through for managed-care and eye-care peers if investors broaden to profitability and margin improvement narratives.

Regional

Limited, primarily US-listed healthcare/consumer health sentiment.

Global

Low; guidance is company-specific with no stated cross-border policy or supply shock.

Counterpoint

What could challenge this read

The guidance ranges are only modestly higher, so the stock may fade if investors expected a larger step-up or if margins depend on temporary operating efficiencies.

Key entities

  • company
    Bausch + Lomb Corp.

    Reported Q3 fiscal 2026 profitability and lifted FY26 revenue and adjusted EBITDA guidance ranges.

  • venue
    New York Stock Exchange

    Shares were trading about 2.10% higher in pre-market hours per the article.

Read at source← All news

StoryBausch + Lomb posts Q3 profit and lifts full‑year 2026 guidance

Also covered by

5 outlets

Related articles

OCT 28
$BLCOHighAI 9/10

Why is Bausch + Lomb stock surging today?

Bausch + Lomb (BLCO) stock rose 7.3% after Q3 2026 earnings beat estimates, with adjusted EPS of $0.34 vs. $0.21 expected, and revenue of $1.375B, up 7% YoY. The company raised full-year guidance for the third time, citing growth across all segments and improved profitability. The stock reached a 52-week high of $19.09.

investing.com2 min
OCT 28
$BLCOMedAI 8/10

Bausch + Lomb (BLCO) Q3 2026 Earnings Call Transcript

Bausch + Lomb (BLCO) reported Q3 2026 earnings with 8% revenue growth to $1.375B, 34% adjusted EBITDA increase, and 23.6% margin. All segments grew: Pharmaceuticals +11%, Surgical +9%, Vision Care +6%. The company reduced net leverage to 4.1x and remains confident in meeting its 3-year plan targets.

finance.yahoo.com2 min
OCT 28
$BLCOHighAI 8/10

Bausch + Lomb Posts 7% Revenue Growth, Raises 2026 Guidance

Bausch + Lomb reported Q3 2026 revenue of $1.375B, up 7% YoY, and net income of $32M. Adjusted EBITDA was $325M, and adjusted diluted EPS was $0.34. The company raised full-year revenue guidance to $5.45B–$5.55B and adjusted EBITDA guidance to $1.09B–$1.14B. All business segments grew, with notable increases in MIEBO and LUMIFY revenues.

tradingview.com1 min